243 related articles for article (PubMed ID: 30341246)
61. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
[TBL] [Abstract][Full Text] [Related]
62. Role of the ubiquitin ligase Fbw7 in cancer progression.
Cheng Y; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
[TBL] [Abstract][Full Text] [Related]
63. A MicroRNA/Ubiquitin Ligase Feedback Loop Regulates Slug-Mediated Invasion in Breast Cancer.
Manne RK; Agrawal Y; Bargale A; Patel A; Paul D; Gupta NA; Rapole S; Seshadri V; Subramanyam D; Shetty P; Santra MK
Neoplasia; 2017 Jun; 19(6):483-495. PubMed ID: 28500896
[TBL] [Abstract][Full Text] [Related]
64. Orientia tsutsugamushi Strain Ikeda Ankyrin Repeat-Containing Proteins Recruit SCF1 Ubiquitin Ligase Machinery via Poxvirus-Like F-Box Motifs.
Beyer AR; VieBrock L; Rodino KG; Miller DP; Tegels BK; Marconi RT; Carlyon JA
J Bacteriol; 2015 Oct; 197(19):3097-109. PubMed ID: 26170417
[TBL] [Abstract][Full Text] [Related]
65. Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis.
Pagano M
Mol Cell; 2004 May; 14(4):414-6. PubMed ID: 15149588
[TBL] [Abstract][Full Text] [Related]
66. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
67. Prognostic impact of Skp2 and p27 in human breast cancer.
Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
[TBL] [Abstract][Full Text] [Related]
68. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
Chen G; Wang Y; Garate M; Zhou J; Li G
Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
[TBL] [Abstract][Full Text] [Related]
69. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
Chen JY; Wang MC; Hung WC
J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
[TBL] [Abstract][Full Text] [Related]
70. F-box proteins that contain sugar-binding domains.
Yoshida Y
Biosci Biotechnol Biochem; 2007 Nov; 71(11):2623-31. PubMed ID: 17986767
[TBL] [Abstract][Full Text] [Related]
71. Emerging roles of F-box proteins in cancer drug resistance.
Yan L; Lin M; Pan S; Assaraf YG; Wang ZW; Zhu X
Drug Resist Updat; 2020 Mar; 49():100673. PubMed ID: 31877405
[TBL] [Abstract][Full Text] [Related]
72. The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels.
Dutta P; Islam S; Choppara S; Sengupta P; Kumar A; Kumar A; Wani MR; Chatterjee S; Santra MK
J Biol Chem; 2019 Oct; 294(41):14879-14895. PubMed ID: 31413110
[TBL] [Abstract][Full Text] [Related]
73. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.
Liu L; Yang J; Wang C
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318
[TBL] [Abstract][Full Text] [Related]
74. Bioinformatics analysis of prognostic value of
Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
[No Abstract] [Full Text] [Related]
75.
Wang YF; Han J
Biochem Cell Biol; 2019 Dec; 97(6):750-757. PubMed ID: 30897334
[TBL] [Abstract][Full Text] [Related]
76. Association of mRNA expression levels of Cullin family members with prognosis in breast cancer: An online database analysis.
Liu A; Zhang S; Shen Y; Lei R; Wang Y
Medicine (Baltimore); 2019 Aug; 98(31):e16625. PubMed ID: 31374029
[TBL] [Abstract][Full Text] [Related]
77. F-box proteins and gastric cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.
Yang Y; Xie Q; Hu C; Xu J; Chen L; Li Y; Luo C
Int J Med Sci; 2024; 21(8):1575-1588. PubMed ID: 38903918
[TBL] [Abstract][Full Text] [Related]
78. FBXW2 suppresses proliferation and invasion of lung cancer cells by targeting SKP2 and β-catenin.
Yang F; Sun Y
Mol Cell Oncol; 2019; 6(4):1607458. PubMed ID: 31211237
[TBL] [Abstract][Full Text] [Related]
79. Aberrant Expression of Cancer-Testis Antigen FBXO39 in Breast Cancer and its Clinical Significance.
Liu YC; Yan S; Liu DM; Pei DX; Li YW
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902238
[TBL] [Abstract][Full Text] [Related]
80. A Comprehensive Analysis Revealing FBXW9 as a Potential Prognostic and Immunological Biomarker in Breast Cancer.
Yu S; Liang Z; Fan Z; Cao B; Wang N; Wu R; Sun H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
